While many patients are suitable candidates, tirzepatide is not for everyone
Using expired tirzepatide may result in inadequate glycemic control or insufficient weight management effects, potentially leading to disease progression or treatment failure
approved options with clear dosing will emerge Medical supervision is essential These potent compounds require qualified medical oversight Alternatives exist CagriSema and other evidence-based combinations offer proven approaches The rapid evolution of metabolic peptide research means today's experimental combinations may become tomorrow's standard therapiesor may prove ineffective or unsafe
Why It Matters These medications work by lowering blood-sugar levels and are typically used to treat those with type 2 diabetes, but more recently have also been used for weight loss and obesity
In the following review article, we aim at reviewing the evidence related to the impact of GLP-1 RAs, on gastrointestinal procedures, mainly EGDs and colonoscopies, and their implications on the peri-operative period